Septerna Inc (SEPN)
$36.42-3.04%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- 2.28
- P/E (TTM)
- -67.44
- Short % float
- 16.40%
- Days to cover
- 8.8
- SI change
- +7.0%
- 1W
- +2.10%
- 1M
- -7.91%
- vs SPY 1W
- +2.24%
- vs SPY 1M
- -10.42%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on SEPN?
- LOPJLB’s latest quantitative signal on Septerna Inc (SEPN) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is SEPN in?
- Septerna Inc (SEPN) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Septerna Inc (SEPN) do?
- Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX…